← Eichor
Study identifier: NCT04251143 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Dresden Corneal Disease and Treatment Study

Condition: Corneal Ectasia · Corneal Disease · Corneal Astigmatism  ·  Sponsor: Technische Universität Dresden

PhaseN/A
Planned participants700
Who can joinAll sexes, 18 Years to 65 Years
Healthy volunteersNo

About this study

The purpose of this study is long-term follow up of patients with corneal diseases to analyze the quality of surgical interventions and diagnosis. Corneal ectasia, especially keratoconus, is a corneal disease that leads to an irreversible loss of visual acuity while the cornea becomes steeper, thinner and irregular. For these patients, surgical intervention (e.g. corneal cross-linking) is performed, in case of disease progression. Overall, a long-term follow up is needed to evaluate an early disease progression as well as corneal stability after surgical intervention.

This description comes directly from the study's public registry record.

Talk to the study team

Robert Herber, MSc  ·  004935145815091  ·  robert.herber@uniklinikum-dresden.de

Janine Lenk, MD

Always discuss trial participation with your own doctor first.

Locations (1)

Department of Ophthalmology; Medical Faculty Carl Gustav Carus; Technical University DresdenDresden, Saxony, GermanyRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04251143